Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-05T06:49:00.840Z Has data issue: false hasContentIssue false

5 - Cannabis and psychosis proneness

Published online by Cambridge University Press:  07 December 2009

Hélène Verdoux
Affiliation:
University Victor Segalen, Bordeaux, France
David Castle
Affiliation:
Mental Health Research Institute, Melbourne
Robin Murray
Affiliation:
Institute of Psychiatry, London
Get access

Summary

In many countries, a large proportion of the general population is now exposed to cannabis, as a result of its widespread recreational use (Webb et al., 1996; Smart and Ogborne, 2000). From a public health point of view, a careful assessment of the impact of cannabis on mental health in general-population subjects is thus warranted, in order to decide whether prevention strategies aimed at reducing exposure to this drug are justified. Investigation of the mental health characteristics of cannabis users in the general population is especially important for identification of a potential aetiological risk factor for severe mental illness. Converging findings obtained by prospective population-based cohort studies suggest that cannabis use may be an independent risk factor for the onset of psychosis (Andreasson et al., 1987; Arseneault et al., 2002; van Os et al., 2002; Weiser et al., 2002).

However, the nature of the link between cannabis use and psychosis is far from being elucidated. Findings drawn from clinical samples of subjects identified as cases of psychosis have limited value in shedding light on the mechanisms underlying this association, as the potential confounding factors linked to the clinical status of the subjects are difficult to control in such samples. Thus, studies exploring factors modulating the expression of psychosis in non-clinical populations may better identify causal risk factors for psychosis than studies carried out in clinical samples (Verdoux et al., 1998b, van Os et al., 2000; 2001; Verdoux and van Os, 2002).

Type
Chapter
Information
Marijuana and Madness
Psychiatry and Neurobiology
, pp. 75 - 88
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allebeck, P, Adamsson, C, Engstrom, A. and Rydberg, U. (1993). Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatr. Scand., 88, 21–24CrossRefGoogle ScholarPubMed
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Association
Amorin, P, Lecrubier, Y, Weiller, E, Hergueta, T. and Sheehan, D. (1998). DSM-III-R psychotic disorders: procedural validity of the MINI International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur. Psychiatry, 13, 26–34CrossRefGoogle Scholar
Andreasson, S, Allebeck, P, Engstrom, A. and Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483–1486CrossRefGoogle ScholarPubMed
Arndt, S, Tyrrell, G, Flaum, M. and Andreasen, N. C. (1992). Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol. Med., 22, 379–388CrossRefGoogle ScholarPubMed
Arseneault, L, Cannon, M, Poulton, R.et al. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br. Med. J., 325, 1212–1213CrossRefGoogle ScholarPubMed
Ashton, C. (2001). Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry, 178, 101–106CrossRefGoogle ScholarPubMed
Castle, D. J. and Ames, F. R. (1996). Cannabis and the brain. Aust. NZ J. Psychiatry, 30, 179–183CrossRefGoogle Scholar
Chapman, L, Chapman, J, Kwapil, T, Eckblad, M. and Zinser, M. (1994). Putatively psychosis-prone subjects 10 years later. J. Abnormal Psychol., 103, 171–183CrossRefGoogle ScholarPubMed
Claridge, G. (1997) Theoretical background and issues. In: Schizotypy. Implications for Illness and Health, ed. G. Claridge, pp. 3–18. Oxford: Oxford University Press
Claridge, G. and Beech, T. (1995) Fully and quasi-dimensional constructions of schizotypy. In Schizotypal Personality, ed. A. Raine, T. Lencz and S. A. Mednick, pp. 192–216. Cambridge: Cambridge University Press
Csikszentmihalyi, M. and Larson, R. (1987). Validity and reliability of the Experience-Sampling Method. J. Nerv. Ment. Dis., 175, 526–536CrossRefGoogle ScholarPubMed
Delespaul, P. (1995) Assessing Schizophrenia in Daily Life. Maastricht: Universitaire Press
Dixon, L, Haas, G, Weiden, P. J., Sweeney, J. and Frances, A. J. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry, 148, 224–230Google ScholarPubMed
Dumas, P, Saoud, M, Bouafia, S.et al. (2002). Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Res., 109, 27–35CrossRefGoogle ScholarPubMed
Eaton, W, Romanoski, A, Anthony, J. C. and Nestadt, G. (1991). Screening for psychosis in the general population with a self-report interview. J. Nerv. Ment. Dis., 179, 689–693CrossRefGoogle ScholarPubMed
Hall, W. and Solowij, N. (1997). Long-term cannabis use and mental health. Br. J. Psychiatry, 171, 107–108CrossRefGoogle ScholarPubMed
Johns, A. (2001). Psychiatric effects of cannabis. Br. J. Psychiatry, 178, 116–122CrossRefGoogle ScholarPubMed
Kibel, D. A., Laffont, I. and Liddle, P. F. (1993). The composition of the negative syndrome of chronic schizophrenia. Br. J. Psychiatry, 162, 744–750CrossRefGoogle ScholarPubMed
Kirkpatrick, B, Amador, X. F., Flaum, M.et al. (1996). The deficit syndrome in the DSM-IV field trial: I. Alcohol and other drug abuse. Schizophr. Res., 20, 69–77CrossRefGoogle ScholarPubMed
Kwapil, T. R. (1996). A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals. J. Abnormal Psychol., 105, 114–123CrossRefGoogle ScholarPubMed
Liraud, F, and Verdoux, H. (2000). Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders?Psychiatry Res., 93, 63–72CrossRefGoogle ScholarPubMed
Mason, G, Claridge, G. and Jackson, M. (1995). New scales for the assessment of schizotypy. Personal. Individ. Differ., 18, 7–13CrossRefGoogle Scholar
Mathers, D. C. and Ghodse, A. H. (1992). Cannabis and psychotic illness. Br. J. Psychiatry, 161, 648–653CrossRefGoogle ScholarPubMed
McGuire, P. K., Jones, P, Harvey, I.et al. (1995). Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr. Res., 15, 277–281CrossRefGoogle ScholarPubMed
Mueser, K. T., Yarnold, P. R., Levinson, D. F.et al. (1990). Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull., 16, 31–56CrossRefGoogle ScholarPubMed
Myin-Germeys, I, Delespaul, P. and Vries, M. (2001a). The context of delusional experiences in the daily life of patients with schizophrenia. Psychol. Med., 31, 489–498CrossRefGoogle Scholar
Myin-Germeys, I, Os, J, Schwartz, J, Stone, A. and Delespaul, P. (2001b). Emotional reactivity to daily life stress in psychosis. Arch. Gen. Psychiatry, 58, 1137–1144CrossRefGoogle Scholar
Nunn, J, Rizza, F. and Peters, E. R. (2001). The incidence of schizotypy among cannabis and alcohol users. J. Nerv. Ment. Dis., 189, 741–748CrossRefGoogle ScholarPubMed
Peralta, V. and Cuesta, M. J. (1992). Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr. Scand., 85, 127–130CrossRefGoogle ScholarPubMed
Peters, E. R., Joseph, S. A. and Garety, P. A. (1999). Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr. Bull., 25, 553–576CrossRefGoogle Scholar
Poulton, R, Caspi, A, Moffitt, T.et al. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder. Arch. Gen. Psychiatry, 57, 1053–1058CrossRefGoogle ScholarPubMed
Raine, A. (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr. Bull., 17, 556–563CrossRefGoogle ScholarPubMed
Salyers, M. and Mueser, K. (2001). Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res., 48, 109–123CrossRefGoogle Scholar
Selten, J. P., Gernaat, H. B., Nolen, W. A., Wiersma, D. and Bosch, R. J. (1998). Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. Am. J. Psychiatry, 155, 350–354CrossRefGoogle ScholarPubMed
Skosnik, P. D., Spatz-Glenn, L. and Park, S. (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr. Res., 48, 83–92CrossRefGoogle ScholarPubMed
Slade, M, Phelan, M, Thornicroft, G. and Parkman, S. (1996). The Camberwell Assessment of Need (CAN): comparison of assessments by staff and patients of the needs of the severely mentally ill. Soc. Psychiatry Psychiatric Epidemiol., 31, 109–113CrossRefGoogle ScholarPubMed
Smart, R. and Ogborne, A. (2000). Drug use and drinking among students in 36 countries. Addict. Behav., 25, 455–460CrossRefGoogle ScholarPubMed
Stefanis, N, Hanssen, M, Smyonis, N.et al. (2002). Evidence that three dimensions of psychosis have a distribution in the general population. Psychol. Med., 32, 347–358CrossRefGoogle ScholarPubMed
Swendsen, J. D. and Norman, S. (1998). Preparing for community violence: mood and behavioral correlates of the second Rodney King verdicts. J. Traumatic Stress, 11, 57–70CrossRefGoogle Scholar
Swendsen, J. D., Tennen, H, Carney, M. A.et al. (2000). Mood and alcohol consumption: an experience sampling test of the self-medication hypothesis. J. Abnormal Psychol., 109, 198–204CrossRefGoogle ScholarPubMed
Tennant, F. S. Jr and Groesbeck, C. J. (1972). Psychiatric effects of hashish. Arch. Gen. Psychiatry, 27, 133–136CrossRefGoogle ScholarPubMed
Thornicroft, G. (1990). Cannabis and psychosis. Is there epidemiological evidence for an association?Br. J. Psychiatry, 157, 25–33CrossRefGoogle ScholarPubMed
Tien, A. (1991). Distributions of hallucinations in the population. Soc. Psychiatry Psychiatric Epidemiol., 26, 287–292CrossRefGoogle ScholarPubMed
Tramèr, M, Carroll, D, Campbell, F.et al. (2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br. Med. J., 323, 16CrossRefGoogle ScholarPubMed
Os, J, Verdoux, H, Maurice-Tison, S.et al. (1999). Self-reported psychosis-like symptoms and the continuum of psychosis. Soc. Psychiatry Psychiatric Epidemiol., 34, 459–463Google ScholarPubMed
Os, J, Hanssen, M, Bijl, R. and Ravelli, A. (2000). Strauss (1969) revisited: a psychosis continuum in the general population?Schizophr. Res., 45, 11–20Google ScholarPubMed
Os, J, Hanssen, M, Bijl, R. V. and Ravelli, A. (2000). Strauss (1969) revisited: a psychosis continuum in the general population?Schizophrenia Research, 45, 11–20Google ScholarPubMed
Os, J, Hanssen, M, Bijl, R. and Vollebergh, W. (2001). Prevalence of psychotic disorder and community level of psychotic symptoms. Arch. Gen. Psychiatry, 58, 663–668Google ScholarPubMed
Os, J, Bak, M, Hanssen, M.et al. (2002). Cannabis and psychosis: a longitudinal population-based study. Am. J. Epidemiol., 156, 319–327Google ScholarPubMed
Venables, P, Wilkins, S, Mitchell, D, Raine, A. and Bailes, K. (1990). A scale for the measurement of schizotypy. Personality Individ. Differ., 11, 481–495CrossRefGoogle Scholar
Verdoux, H. and Os, J. (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res., 54, 59–65CrossRefGoogle ScholarPubMed
Verdoux, H, Maurice-Tison, S, Gay, B.et al. (1998a). A survey of delusional ideation in primary care patients. Psychol. Med., 28, 127–134CrossRefGoogle Scholar
Verdoux, H, Os, J, Maurice-Tison, S.et al. (1998b). Is early adulthood a critical developmental stage for psychosis proneness? A survey of delusional ideation in normal subjects. Schizophr. Res., 29, 247–254CrossRefGoogle Scholar
Verdoux, H, Os, J, Maurice-Tison, S.et al. (1999). Increased occurrence of depression in psychosis-prone subjects. A follow-up study in primary care settings. omp. Psychiatry, 40, 462–468Google ScholarPubMed
Verdoux, H, Gindre, C, Sorbara, F, Tournier, M. and Swendsen, J. (2003a). Cannabis use and the expression of psychosis vulnerability in daily life. Psychol. Med., 33, 23–32CrossRefGoogle Scholar
Verdoux, H, Sorbara, F, Gindre, C, Swendsen, D. and Os, J. (2003b). Cannabis and dimensions of psychosis in a non-clinical population of female subjects. Schizophr. Res., 59, 77–84CrossRefGoogle Scholar
Webb, E, Ashton, C, Kelly, P. and Kamali, F. (1996). Alcohol and drug use in UK university students. Lancet, 348, 922–925CrossRefGoogle ScholarPubMed
Weiser, M, Reichenberg, A, Rabinowitz, J.et al. (2002). Self-reported drug abuse in male adolescents with behavioural disturbances, and follow-up for future schizophrenia. Schizophr. Res., 53 (suppl.), 227Google Scholar
Williams, J. H., Wellman, N. A. and Rawlins, J. N. (1996). Cannabis use correlates with schizotypy in healthy people. Addiction, 91, 869–877CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×